Boston Millennia Partners
Boston Millennia Partners (BMP) is a venture capital firm with a long-standing history of providing growth equity financing to healthcare, business services, and information technology companies. With over 30 years of experience, BMP focuses on building large-scale businesses through strategic consolidation and a 'buy-and-build' approach. The firm leverages its extensive global network and deep industry expertise to support its portfolio companies beyond capital, offering strategic guidance, market analysis, and organizational development.
Boston Millennia Partners
What We Do
BMP provides operational expertise and financial acumen to assist portfolio companies in strategy development and market analysis.
BMP helps portfolio companies organize and build their senior executive talent, maintaining a database of executives seeking career enhancement.
BMP offers legal advice and support to portfolio companies, complementing their outside counsel with experienced legal insights.
BMP assists portfolio companies in raising private capital, organizing syndicates of investors aligned with company managements.
BMP works with portfolio company management to manage expense structures, especially during difficult market conditions.
BMP leverages its extensive network of entrepreneurs and professionals to provide strategic advice and industry expertise to portfolio companies.
Portfolio
Odyssey Logistics & Technology is a full-service outsourced logistics management service provider. BMP has supported Odyssey in completing 14 add-on acquisitions, significantly growing its revenue and earnings.
#Logistics
Collegium Pharmaceutical focuses on developing proprietary, late-stage pharmaceutical products. BMP was the only institutional investor initially, helping Collegium grow and eventually complete an IPO.
#Pharmaceutical
PAREXEL is a flagship core company for BMP, which has supported its growth through strategic acquisitions and international expansion, resulting in a 23,000% return on investment.
#Pharmaceutical Services
Personal Health Technologies, Inc. was acquired, providing significant returns to BMP investors.
#Health Technology
Precision Dermatology was acquired by Valeant Pharmaceuticals for $475,000,000, providing a 350% return to BMP’s Limited Partners.
#Dermatology
Proteome was sold to Incyte Genomics for $77,000,000, providing a 400% return on investment.
#Biotechnology
Key People
Managing Partner
General Partner
Partner
Chief Financial Officer